Southern California College of Optometry at Marshall B. Ketchum University
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Southern California College of Optometry at Marshall B. Ketchum University sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).
Southern California College of Optometry at Marshall B. Ketchum University: 18 sponsored US clinical trials, 2 recruiting.
Southern California College of Optometry at Marshall B. Ketchum University sponsors 18 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 16 completed. 4 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Meibomian Gland Dysfunction, with 1 trials.
Top-decile sponsor footprint
Southern California College of Optometry at Marshall B. Ketchum University ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
16 of 16 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
18 total, page 1 of 1
The Effects of 3% Trehalose Ophthalmic Solution on Corneal Epithelial Barrier Function
NCT06655441
Trial of Vision Therapy for Intermittent Exotropia
NCT04487249
Neurolens and Contact Lens Discomfort
NCT05801991
Eyelid Androgen Treatment in Dry Eye
NCT06154200
Soft Contacts Observation of Risk and Education (SCORE)
NCT03305484
Bepreve vs. Alrex in Subjects With Moderate to Severe Allergic Conjunctivitis
NCT01443442
The Efficacy of an Ocular Emulsion in Meibomian Gland Dysfunction
NCT01207752
The Effect of a New Emulsion in Dry Eye Patients on Tear Layer Aberrometry, Contrast Sensitivity, and Reading Ability
NCT01013077
Tear Film Thickness Measured Using a Novel Technique
NCT01014780
Corneal Staining and Physiological Compromise After Eight Hours of Soft Contact Lens Wear
NCT01015768
The Physiological Consequence of Silicone-hydrogel Care-solution Bio-incompatibility
NCT00829751
Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function
NCT00560898
The Relationship of Residence Time and Visual Effect of Optive and Systane in Dry Eye Subjects
NCT00553579
Corneal Barrier Function With Multi-Purpose Solutions
NCT00407238
Comparison of Systane Free vs. Saline in the Treatment of Dry Eye
NCT00388791
The Effect of Final Exam Preparation on Anxiety Level, Self-Perception, Ocular Symptoms, Accommodation and Vergence in Myopia
NCT00405106
The Visual Effect of an Investigational Artificial Tear in the Tear Layer.
NCT00395759
Visual Discomfort and Reading
NCT00402155
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
| Phase 4 | 4 |
Therapeutic Areas
Where Southern California College of Optometry at Marshall B. Ketchum University enrollment is open (later-stage tilt)
2 recruiting of 18 indexed (11% open); 16 completed (89%).
Phase mix: 4 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Meibomian Gland Dysfunction (1 trial), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Southern California College of Optometry at Marshall B. Ketchum University: open-pipeline peers nationwide
Peers matched on 18 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Southern California College of Optometry at Marshall B. Ketchum University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 18 trials (± recruiting share)
- ADC Therapeutics S.A. · 18 trials · 11% recruiting
- Akros Pharma · 18 trials · 0% recruiting
- AO Clinical Investigation and Publishing Documentation · 18 trials · 0% recruiting
- AO Innovation Translation Center · 18 trials · 33% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
- Amylyx Pharmaceuticals · 11% recruiting · 9 trials
- Aprea Therapeutics · 11% recruiting · 9 trials
Related
What to do with this Southern California College of Optometry at Marshall B. Ketchum University page
18 registered trials is a research-attention snapshot, not an endorsement of Southern California College of Optometry at Marshall B. Ketchum University or any single study.
- 2 of Southern California College of Optometry at Marshall B. Ketchum University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Meibomian Gland Dysfunction is the condition Southern California College of Optometry at Marshall B. Ketchum University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Meibomian Gland Dysfunction trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Southern California College of Optometry at Marshall B. Ketchum University pipeline card: 18 registered trials from official public datasets.Report a data error.